ホーム › 前立腺がん › サウスカロライナ › Myrtle Beach
Myrtle Beach、SCにおける前立腺がんの臨床試験
Myrtle Beachとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する24件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
被験者募集中第3相
- Carolina Urologic Research Center, Myrtle Beach
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13マイル先
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
被験者募集中観察研究
- Carolina Urologic Research Center, Myrtle Beach
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Carolina Urologic Research Center, Myrtle Beach
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
被験者募集中第1/2相
- Carolina Urologic Research Center, Myrtle Beach
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, Myrtle Beach
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
被験者募集中第3相
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- START Carolinas, Myrtle Beach
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
被験者募集中第2/3相
- Carolina Urologic Research Center, Myrtle Beach
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
被験者募集中第3相
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Carolina Urologic Research Center, Myrtle Beach
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
被験者募集中第3相
- Research Site, Myrtle Beach
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
被験者募集中第2相
- START Carolinas, Myrtle Beach
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
被験者募集中第3相
- Carolina Urologic Research Center, Myrtle Beach
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
被験者募集中第2相
- Carolina Urologic Research Center, Myrtle Beach
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
被験者募集中第3相
- Research Site, Myrtle Beach
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
被験者募集中第2相
- Carolina Urologic Research Center, Myrtle Beach
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
被験者募集中第1相
- Carolina Urologic Research Center, Myrtle Beach
PSMA PET Combined With MRI for the Detection of PCa
被験者募集中第3相健康なボランティア歓迎
- Atlantic Urology Specialists, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
被験者募集中第1相
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
被験者募集中第1相
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
被験者募集中第1相
- Carolina Urologic Research Center, Myrtle Beach
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Carolina Regional Cancer Center, Myrtle Beach
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
被験者募集中第2相
- Carolina Urologic Research Center, Myrtle Beach
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Myrtle Beachにおける他の研究
- 膀胱癌10件の研究
- 非筋層浸潤性膀胱癌9件の研究
- 腎臓がん（腎細胞がん）6件の研究
- 尿路上皮（移行上皮）癌5件の研究
- 転移性癌5件の研究
- 2型糖尿病3件の研究
- 去勢抵抗性前立腺がん3件の研究
- がん（全種類）3件の研究
- 上皮内がん3件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。